Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $7.10 USD
Change Today -0.23 / -3.14%
Volume 1.1M
PGNX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert J. Israel M.D.

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

58$854,541
As of Fiscal Year 2014

Background*

Dr. Robert J. Israel, M.D. served as an Executive Vice President of Innovation at Progenics Pharmaceuticals, Inc., until July 2, 2015 and its Senior Vice President of Medical Affairs & Clinical Research and Senior Vice President of Medical Affairs since 2002. Dr. Israel served as an Executive Vice President of Medical Affairs at Progenics Pharmaceuticals, Inc. Dr. Israel has been a Consultant to the Solid Tumor Service at Sloan-Kettering since 1987. He joined Progenics ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-789-2800
Fax: 914-789-2817

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MD
The University of Pennsylvania
BA
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

Salary$440,938
Total Annual Compensation$440,938

Stock Options*

All Other Compensation$14,623
Exercised Options27,000
Exercised Options Value$42,501
Exercisable Options200,833
Exercisable Options Value$111,230
Unexercisable Options122,667
Unexercisable Options Value$289,960
Total Value of Options$443,691
Total Number of Options350,500

Total Compensation*

Total Annual Cash Compensation$619,535
Total Short Term Compensation$440,938
Other Long Term Compensation$14,623
Total Calculated Compensation$854,541
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGNX:US $7.10 USD -0.23

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer, President and Principal Financial Officer
Arena Pharmaceuticals, Inc.
$746.8K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$964.7K
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$517.2K
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$398.8K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGENICS PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.